Prior authorization denials are about to get a paper trail. State regulators vote Monday on the exam that puts insurer algorithms on the record. The vote is scheduled for the NAIC’s 2026 Fall National Meeting in Dallas, which runs November 14–17. The NAIC’s November 13 meeting announcement says the agenda addresses coverage availability and affordability, artificial intelligence, fraud, and severe-weather resilience. Virginia Insurance Commissioner and NAIC President Scott A. White is scheduled to deliver the Sunday keynote. White said the state-based system has remained at the forefront of change by anticipating risk and working together to help manage it.
MONDAY AGENDA: AI RISK EVALUATION SUPPLEMENT V7.0
The NAIC’s Big Data and Artificial Intelligence (H) Working Group is scheduled to meet Monday, November 16, from noon to 1 p.m. Central Time at the Dallas Convention Center. Commissioner Nathan Houdek of Wisconsin chairs the working group. Agenda item 4 is “Consider Adoption of the AI Risk Evaluation Supplement v7.0.” The working group agenda also lists a report on the pilot process and comments from interested parties.
The agenda describes a proposed decision, not a completed one. As of Sunday, November 15, adoption has not been confirmed.

WHAT THE SUPPLEMENT WOULD ADD TO EXAMINER REVIEW
The NAIC describes the supplement as a tool for state examiners reviewing how an insurer uses artificial intelligence. It supplements existing examiner handbooks; it is not a consumer-facing disclosure form. The NAIC staff summary of changes describes v7.0 as collecting supporting documents to corroborate company responses, rather than relying only on answers to a questionnaire.
Among the changes described by NAIC staff:
- Insurers are asked to provide a model inventory. The supplement separates models with “Direct Consumer Impact” from those with “Material Financial Impact.”
- A new inquiry addresses explainability and transparency. Other questions address materiality and oversight of third-party models.
- The supplement defines “agentic AI” and aligns materiality language with the Financial Condition Examiners Handbook.
- Examiners may limit their inquiry in some cases involving generalized linear models (GLMs). GLMs remain within scope by default.
- Companies are asked to identify document names and page numbers supporting their responses.
These are examination questions and instructions. They do not, by themselves, establish what a specific insurer did in a specific coverage decision.
STATE ACTION AND THE SCOPE OF OVERSIGHT
According to the NAIC’s adoption map, as of November 13, 28 states plus the District of Columbia and Puerto Rico had adopted the NAIC Model Bulletin, “Use of Artificial Intelligence Systems by Insurers.” The model bulletin was adopted by the NAIC on December 4, 2023. The map separately identifies California, Colorado, and New York as having insurance-specific AI regulations or guidance.
KFF Health News reported that Arizona, Maryland, Nebraska, and Texas enacted legislation addressing AI in health insurance in the prior year, while Illinois and California did so the year before. Its February 2026 reporting also described a December 2025 executive order seeking to preempt most state AI regulation. The relationship between state rules and federal action remains relevant to the reach of oversight.
The KFF Health News report noted that Cigna CEO David Cordani told a congressional committee AI was “never used for a denial.” Cigna separately said its claims-denial process “is not powered by AI.” These are the companies’ stated positions, not independent confirmation of how a particular determination was made.
KFF also reported University of Minnesota law professor Daniel Schwarcz’s observation that many state laws call for human sign-off on AI-proposed decisions without specifying how much review is sufficient. The same report noted that states cannot regulate self-insured employer plans; that authority rests with the federal government.
WHAT A DENIAL NOTICE CAN TELL YOU
A denial may involve a medical-necessity judgment, a benefit exclusion, or a network rule. The wording and basis matter. A medical-necessity denial usually means the plan determined that the requested service did not meet its clinical criteria. A benefit-exclusion denial says the plan does not cover the service under the policy. A network denial may concern where care was received or whether a provider participates in the plan.
The distinction affects the next steps. HealthCare.gov says external review is available for denials involving medical judgment, including disputes about whether treatment is experimental or investigational. A benefit-exclusion or network denial may still be appealed internally, but it is not automatically eligible for external review unless the dispute also involves a qualifying medical judgment or another applicable basis.
Start with the written denial notice or Explanation of Benefits (EOB). Request the specific coverage provision relied on, the clinical criteria or medical policy applied, and the records or other materials considered. Ask the plan to identify whether the decision was based on benefit terms, network status, or medical necessity. The notice should explain the reason for the denial and provide appeal instructions.

QUESTIONS TO SEND THE PLAN IN WRITING
A written request can help preserve a clear record of what the plan says. Questions can include:
- What exact policy provision, medical policy, or clinical criteria were applied?
- What documents and clinical records were considered? Can copies be provided?
- Did a specific AI model, algorithm, or automated system contribute to the determination? If so, what is the model’s name, and what role did it play?
- Did a clinician review the file before the denial was issued? If so, what qualifications or specialty did the reviewer have?
- What appeal route applies, what is the filing deadline, and which organization handles any external review?
The supplement’s examiner questions do not establish that a plan must answer each consumer question or disclose an algorithm. The plan’s response should be kept with the denial notice, appeal submissions, and related correspondence.
APPEAL DEADLINES
The following deadlines are listed by HealthCare.gov. The notice for the specific plan should be checked for applicable instructions and the correct filing destination.
| Stage | Listed deadline |
|---|---|
| Insurer’s written notice for a prior authorization request | Within 15 days |
| Insurer’s written notice for services already received | Within 30 days |
| Insurer’s written notice for urgent care | Within 72 hours |
| File an internal appeal | Within 180 days of the denial notice |
| Internal appeal decision for services not yet received | Within 30 days |
| Internal appeal decision for services already received | Within 60 days |
| File a written external review request | Within 4 months of the final denial notice |
| Standard external review decision | No later than 45 days |
| Expedited external review decision | No later than 72 hours |
| Urgent external review requested alongside internal appeal | Final decision within 4 business days |
HealthCare.gov’s internal appeal guidance says the insurer must provide a written decision at the end of the internal process and explain how to request external review. For urgent situations, an external review may be requested at the same time as an internal appeal.
The external review guidance says the insurer is required by law to accept the external reviewer’s decision. Where the HHS-administered federal process applies, there is no charge. If a state process or outside review organization applies, the charge cannot exceed $25 per review. The EOB or final internal denial letter should identify the organization handling external review. A state Consumer Assistance Program or Department of Insurance may also provide filing assistance.
WHAT THE REGULATORY VOTE DOES NOT PROVIDE
The NAIC supplement may give examiners a model inventory and specific questions about explainability, transparency, and third-party model oversight. That is a supervisory examination tool, not a consumer right. Nothing in the supplement obliges an insurer to show a policyholder which model was involved in a denial.
For a consumer considering assistance with an appeal or review of a denial, state license status and National Producer Number (NPN) can be checked through VerifiedAgent’s state lookup before sharing claim or policy details. License records do not establish that a person is qualified to provide legal or medical advice.
The Monday agenda item could add structure to how regulators examine insurers’ AI practices. It does not resolve the facts behind any individual denial, confirm whether AI contributed to a particular decision, or replace the appeal rights and deadlines in the applicable plan. Information and current rules should be independently confirmed with the plan and the relevant regulator.